Advertisement

Topics

Roche's Ocrevus MS drug approved in EU

06:18 EST 12 Jan 2018 | pharmaphorum

Roche’s star multiple sclerosis (MS) drug Ocrevus (ocrelizumab) infusion has been approved in Europe, the first and only approved disease-modifying drug for a debilitating form of the disease. EU approval was a formality after Ocrevus won backing ...

Original Article: Roche's Ocrevus MS drug approved in EU

NEXT ARTICLE

More From BioPortfolio on "Roche's Ocrevus MS drug approved in EU"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...